Relafen belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). While this medication has been licensed to treat the symptoms of osteoarthritis and rheumatoid arthritis, it is not a cure -- nor does it slow down the progression of the disease. Relafen comes in the form of a tablet that is taken by mouth. Common side effects include swelling, unexplained rash, and constipation.
What Is Relafen?
Relafen® (nabumetone) is a prescription medicine used to treat pain, inflammation, swelling, and/or stiffness. It belongs to a class of drugs called nonsteroidal anti-inflammatory drugs, or NSAIDs for short.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Relafen [package insert]. Research Triangle Park, NC: GlaxoSmithKline;2006 February.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: Approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click